Chief Executive Officer
Kyverna Therapuetics
Emeryville, CA, USA
228: KYV-101 Anti-CD19 CAR T-Cell Therapy: The Future of Autoimmune Disease Treatment
Monday, November 18, 2024
5:45 PM – 7:45 PM Eastern Time
No financial relationships with ineligible companies to disclose